Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Poor Prognosis
100%
Hepatocellular Carcinoma
100%
Cancer Aggressiveness
100%
Uridine-cytidine Kinase 2
100%
Knockdown
18%
Hepatocellular Carcinoma Patients
18%
Aggressiveness
9%
Tumor Growth in Vivo
9%
Cell Proliferation
9%
Overexpression
9%
Tumor Progression
9%
Multivariate Analysis
9%
Cell Migration
9%
Gene of Interest
9%
Prognostic Factors
9%
Tumorigenesis
9%
Transcriptome Analysis
9%
Cell Invasion
9%
Targeted Therapy
9%
Bioinformatics Analysis
9%
Opposite Effects
9%
Potential Biomarkers
9%
Poor Survival
9%
Public Database
9%
Functional Genes
9%
Clinical Samples
9%
In Vitro Experiment
9%
In Vivo Tumorigenicity
9%
Hepatocellular Carcinoma Cells
9%
Advanced Hepatocellular Carcinoma
9%
Malignant Behavior
9%
Adherens Junction
9%
Dismal Prognosis
9%
Experiment in Vivo
9%
Splicesome
9%
Biochemistry, Genetics and Molecular Biology
Upregulation
100%
Phosphotransferase
100%
Kinase
100%
Uridine
100%
Cytidine
100%
Tumor Progression
18%
Bioinformatics
9%
Cell Proliferation
9%
Carcinogenesis
9%
Multivariate Analysis
9%
Cell Invasion
9%
Cell Migration
9%
Animal Model
9%
Adherens Junction
9%
Targeted Therapy
9%
Medicine and Dentistry
Malignant Neoplasm
100%
Upregulation
100%
Hepatocellular Carcinoma
100%
Uridine Kinase
100%
Tumor Progression
18%
In Vitro
9%
Cell Proliferation
9%
Carcinogenesis
9%
Cell Migration
9%
Targeted Therapy
9%
Cell Invasion
9%
Biological Marker
9%
Carcinogenicity
9%
Adherens Junction
9%
Hepatocellular Carcinoma Cell Line
9%
Multivariate Analysis
9%
Independent Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Liver Cell Carcinoma
100%
Uridine Kinase
100%
Tumor Growth
18%
Carcinogenesis
9%
Biological Marker
9%
Carcinogenicity
9%